EMA Set To Adopt Safe-Use Recommendations For Anti-Epilepsy Drug Valproate

 
• By Vibha Sharma

The European Medicines Agency is scheduled to adopt final recommendations for improving the safety of the anti-epileptic drug valproate – the subject of the agency’s very first public hearing.

Microphones
Valproate was the subject of the EMA's first ever public hearing • Source: Shutterstock

More from Drug Safety

More from Pink Sheet